Agenda for Targovax’s Capital Markets Day 18 February 2021
Oslo, 11 February 2021 – Targovax ASA, a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, will host a virtual Capital Markets Day for investors, analysts and journalists on 18 February 2021 at 2:30 PM CET. The Capital Markets Day will feature presentations from executive management and Alexander Shousthari, Medical Oncologist at Memorial Sloan Kettering Cancer Center, and will be webcast live and accessible at https://www.targovax.com/en/capital-markets-day-2021/ Based on the strong clinical data that are now generated on ONCOS-102,